星点设计-效应面法优化芷芎散温敏凝胶的处方及其鼻黏膜渗透特性研究

被引:15
作者
卢浩扬
林媛媛
车俊秀
曾维东
陈宝
吴传斌
徐月红
机构
[1] 中山大学药学院
基金
广东省科技计划;
关键词
白芷; 川芎; 泊洛沙姆; 温敏凝胶; 体外释放; 鼻黏膜渗透性;
D O I
暂无
中图分类号
R283.6 [剂型];
学科分类号
100802 [中药炮制学];
摘要
目的制备并优化芷芎散鼻用温敏凝胶的处方,并考察其体外释放机制和鼻黏膜渗透特性。方法利用星点设计-效应面法优化泊洛沙姆温敏凝胶基质处方,然后经Franz扩散池法考察欧前胡素、阿魏酸的体外释放机制及其离体家兔鼻黏膜渗透特性。结果最优处方为泊洛沙姆407(P407)20%、泊洛沙姆188(P188)6.5%,欧前胡素接近零级释放模型,阿魏酸接近Higuchi模型,处方对欧前胡素和阿魏酸的透过鼻黏膜均具有促进作用。结论优化所得的处方为芷芎散新给药途径制剂的开发提供基础。
引用
收藏
页码:1845 / 1849
页数:5
相关论文
共 15 条
[1]
Thermoreversible in situ gelling poloxamer-based systems with chitosan nanocomplexes for prolonged subcutaneous delivery of heparin: Design and in vitro evaluation [J].
Radivojsa, Maja ;
Grabnar, Iztok ;
Grabnar, Pegi Ahlin .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 50 (01) :93-101
[2]
Rheological characterization and permeation behavior of poloxamer 407-based systems containing 5-aminolevulinic acid for potential application in photodynamic therapy [J].
van Hemelrijck, Carlos ;
Mueller-Goymann, Christel C. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2012, 437 (1-2) :120-129
[3]
Poloxamer/cyclodextrin/chitosan‐based thermoreversible gel for intranasal delivery of fexofenadine hydrochloride.[J].Hyun‐JongCho;PrabagarBalakrishnan;Eun‐KyoungPark;Ki‐WonSong;Soon‐SunHong;Tae‐YoungJang;Kyu‐SungKim;Suk‐JaeChung;Chang‐KooShim;Dae‐DukKim.J. Pharm. Sci..2010, 2
[4]
RPMI 2650 epithelial model and three-dimensional reconstructed human nasal mucosa as in vitro models for nasal permeation studies.[J].Annette Wengst;Stephan Reichl.European Journal of Pharmaceutics and Biopharmaceutics.2009, 2
[5]
In vitro permeation of desmopressin across rabbit nasal mucosa from liquid nasal sprays: The enhancing effect of potassium sorbate.[J].Bortolotti Fabrizio;Balducci Anna Giulia;Sonvico Fabio;Russo Paola;Colombo Gaia.European Journal of Pharmaceutical Sciences.2008, 1
[6]
In situ gel based on gellan gum as new carrier for nasal administration of mometasone furoate.[J].Shi-lei Cao;Xiao-wei Ren;Qi-zhi Zhang;En Chen;Feng Xu;Jun Chen;Li-Chun Liu;Xin-guo Jiang.International Journal of Pharmaceutics.2008, 1
[7]
Intranasal delivery: Physicochemical and therapeutic aspects.[J].Henry R. Costantino;Lisbeth Illum;Gordon Brandt;Paul H. Johnson;Steven C. Quay.International Journal of Pharmaceutics.2007, 1
[8]
Migraine: Current concepts and emerging therapies [J].
Arulmozhi, DK ;
Veeranjaneyulu, A ;
Bodhankar, SL .
VASCULAR PHARMACOLOGY, 2005, 43 (03) :176-187
[9]
A novel in situ gel for sustained drug delivery and targeting.[J].Sudipta Ganguly;Alekha K Dash.International Journal of Pharmaceutics.2004, 1
[10]
Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC).[J].J Siepmann;N.A Peppas.Advanced Drug Delivery Reviews.2001, 2